Chugai Pharmaceutical Co Ltd (4519.T)
2,299JPY
7:00am BST
¥-134 (-5.51%)
¥2,422
¥2,452
¥2,490
¥2,299
2,238,500
1,621,518
¥2,550
¥1,379
4519.T
About
Overall
| Beta: | 0.62 |
| Market Cap (Mil.): | ¥1,361,716.00 |
| Shares Outstanding (Mil.): | 559.69 |
| Dividend: | 22.00 |
| Yield (%): | 1.64 |
Financials
| 4519.T | Industry | Sector | |
|---|---|---|---|
| P/E (TTM): | 27.74 | 35.19 | 35.42 |
| EPS (TTM): | 87.71 | -- | -- |
| ROI: | 9.55 | 19.50 | 18.86 |
| ROE: | 9.66 | 20.27 | 19.73 |
Sony to name Chugai Pharma's CEO as chairman-Nikkei
May 18 - Sony Corp plans to appoint Chugai Pharmaceutical Co Chief Executive Osamu Nagayama as chairman, the Nikkei reported.
Roche says no plans to change holding in Japan's Chugai
LONDON, April 11 - Swiss drugmaker Roche has no plans to change its holding in Japan's Chugai Pharmaceutical and the recent weakening of the yen would not be a reason to trigger such a move.
Roche says Japan approves new formulation of arthritis drug
ZURICH - Roche Holding AG's Japanese subsidiary Chugai said on Monday that Japanese health regulators have approved a new formulation of its rheumatoid arthritis drug Actemra.
Roche says Japan approves new formulation of arthritis drug
ZURICH, March 25 - Roche Holding AG's Japanese subsidiary Chugai said on Monday that Japanese health regulators have approved a new formulation of its rheumatoid arthritis drug Actemra.
Earnings vs. 
Estimates
Analyst Research Reports
| Report Title | Price |
|---|---|
|
Provider: Reuters Investment Profile
|
£10.00
|
|
Provider: GlobalData
|
£81.00
|
|
Provider: GlobalData
|
£81.00
|
|
Provider: Datamonitor
|
£81.00
|
|
Provider: GlobalData
|
£81.00
|
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.
Thomson Reuters is the world's largest international multimedia news agency, providing investing news, world news, business news, technology news, headline news, small business news, news alerts, personal finance, stock market, and mutual funds information available on Reuters.com, video, mobile, and interactive television platforms. Thomson Reuters journalists are subject to an Editorial Handbook which requires fair presentation and disclosure of relevant interests.
NYSE and AMEX quotes delayed by at least 20 minutes. Nasdaq delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.
